| Literature DB >> 35455484 |
Xiaoyan Wu1, Khurram Abbas1, Yuxiang Yang1, Zijian Li2, Antonio Claudio Tedesco1,3, Hong Bi1,2.
Abstract
The misuse of many types of broad-spectrum antibiotics leads to increased antimicrobial resistance. As a result, the development of a novel antibacterial agent is essential. Photodynamic antimicrobial chemotherapy (PACT) is becoming more popular due to its advantages in eliminating drug-resistant strains and providing broad-spectrum antibacterial resistance. Carbon dots (CDs), zero-dimensional nanomaterials with diameters smaller than 10 nm, offer a green and cost-effective alternative to PACT photosensitizers. This article reviewed the synthesis methods of antibacterial CDs as well as the recent progress of CDs and their nanocomposites in photodynamic sterilization, focusing on maximizing the bactericidal impact of CDs photosensitizers. This review establishes the base for future CDs development in the PACT field.Entities:
Keywords: antimicrobial; carbon dots; light activation; photodynamic effect; reactive oxygen species
Year: 2022 PMID: 35455484 PMCID: PMC9032997 DOI: 10.3390/ph15040487
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Figure 1General bactericidal mechanisms of action of CDs. (a) Schematic representation of the initial electrostatic interaction between CDs and the bacterial cell wall. (b) CDs internalization, intercalation in the bacterial membrane, and irreversible disruption with a leak of cytoplasmatic material. (c) CDs-promoted bacterial photodynamic inactivation with ROS production and DNA damage. Reproduced with permission from Ref. [10]. Copyright © 2021 Nanomaterials MDPI.
Figure 2Schematic illustration of three types of mechanisms in PDT. Reproduced with permission from Ref. [59]. Copyright © 2022 Chem Elsevier B.V.
Figure 3(a) Schematic illustration of synthesis of MCDs by thermal treatment at various temperatures and surface functionalization with DHLA. Reproduced with permission from Ref. [78]. Copyright © 2017, Sensors and Actuators B: Chemical, Elsevier B.V. (b) Brief description of the procedures carried out in this study. In vivo and in vitro PACT studies evaluated PACT mediated by CDs and blue LED light against S. aureus. Reproduced with permission from Ref. [80]. Copyright © 2021 Frontiers in Microbiology, Romero, Alves, Stringasci, Buzzá, Ciol, Inada and Bagnato. (c) Two-photon luminescence images of E. coli and MRSA Excitation wavelength: 800 nm. Delivered dose: OD600 ∼ 0.05 of bacteria and 0.50 μg mL−1 GQD-AbLPS and 0.50 μg mL−1 GQD-Abprotein A, respectively. Reproduced with permission from Ref. [83]. Copyright © 2022 ACS Applied Materials & Interfaces, American Chemical Society.
Figure 4Relationship between phosphorescence (delay time of 1 ms) and the oxygen activation performance of CDs. (a) Fluorescence and phosphorescence (in PVA matrix) spectra of four types of CDs. Inset shows the solution of CDs at different temperatures of synthesis. (b) 1O2 phosphorescence emission spectrum of the four types of CDs in a CD3CN−D2O mixed solvent (v/v = 15/1). (c) TMB photo-oxidation efficiencies of the four CDs. Reproduced with permission from Ref. [43]. Copyright © 2022 ACS Applied Materials & Interfaces, American Chemical Society.
Figure 5(a) Photodynamic efficiency of CDs-NH2 for the inactivation of E. coli K12-MG 1655 upon irradiation at 0.30 W for 10 and 20 min and influence of the CDs-NH2 and CDs-AMP concentration on the treatment efficiency of E. coli without (solid lines) and with (dash lines) visible light illumination (20 min, 0.30 W). Reproduced with permission from Ref. [96]. Copyright © 2018 Colloids and Surfaces B: Biointerfaces, Elsevier B.V. (b) Scheme for Synthesis of CDs, conjugation of the CDs to BSA, and subsequent creation of BSA-CDs nanoparticles for visible-light-induced ROS generation and simultaneous release of ciprofloxacin for antibacterial activity. Reproduced with permission from Ref. [100]. Copyright © 2022 ACS Applied Materials & Interfaces, American Chemical Society.
Figure 6(a) (left) E. coli (5 min irradiation) and (right) M. Luteus colonies (2 min irradiation) in PBS before and after irradiation and their percentage irradiation of MBGQD with 660 nm light. Reproduced with permission from Ref. [102]. Copyright 2018 Photodiagnosis and Photodynamic Therapy, Elsevier B.V. (b) Effects of optimized blue light and optimized cur-GQD concentration on NIH/3t3 cells, indicating nontoxic effect of light dose at 30 J cm−2 with cur-GQD. Reproduced with permission from Ref. [103]. Copyright © 1999–2022 Photochemistry and Photobiology, John Wiley & Sons. (c) Synthesis of the CDs/Cur nanocomposite photosensitizer, and bactericidal activities of CDs/Cur upon dual-wavelength (405 + 808 nm) illumination. Reproduced with permission from Ref. [104]. Copyright 2022 ACS Applied Bio Materials, American Chemical Society. (d) Scheme for conjugation of cytosine, rich single-stranded DNA to CDs and PpIX for hydrogel formation. The blue and red color-coded DNA sequence is the same. Reproduced with permission from Ref. [105]. Copyright © 2019 Journal of Colloid and Interface Science, Elsevier Inc.
Figure 7(a) Diagram of a CDs-embedded hyaluronic acid-based hydrogel (CDgel) for photoablation of infectious bacteria. Infectious bacteria such as S. aureus and E. coli produce hyaluronidases (HAase) when they increase. The CD gel’s hyaluronic acid is decomposed by hyaluronidases, resulting in the release of the CDs. The released CDs use 1O2 production to photodynamically ablate infectious bacteria, allowing for the selective and targeted removal of malignant germs from infected wounds. Reproduced with permission from Ref. [110]. Copyright © 2022 ACS Applied Bio Materials, American Chemical Society. (b) Schematic illustration of the synthesis of BC/QPCuRC@MSiO2@PDA and their related biological applications. Reproduced with permission from Ref. [111]. Copyright © 2021 Journal of Colloid and Interface Science, Elsevier Inc.
Representative CDs for killing microorganisms; from Section 3 and Section 4.
| CDs Label a | The Precursor of CDs | Excitation Wavelength | Emission Wavelength | QY | Light Wavelength | Light Power | ROS Sensitization Yields | Microorganism | Reduction of Bacteria | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| GQD | graphite rods | 328 nm | 494 nm | -- | blue light (470 nm) | 1 W | -- |
| 80% | [ |
| MCDs | edible mushroom | 360 nm | 456 nm | 25% | visible LED light | 2.70 mW cm−2 | -- |
| >90% elimination of | [ |
| CDs | citric acid | 370 nm | 450 nm | -- | blue light (450 nm) | 40 J cm−2 | -- |
| total elimination of | [ |
| GQD | graphite | 480/740 nm | 618–647 nm | 18.50% | 800 nm | 2.64 mW | QY = 0.51 (1O2) | all | [ | |
| Cur-NRCDs | curcumin, neutral red and citric acid | 540 nm | 635 nm | -- | xenon light (400–450 nm) | -- | -- |
| after 10 min of xenon irradiation, 10 mM and 15 mM of Cur-NRCDs can kill 100% of | [ |
| N-GQD (5.1%) | graphite | 365 nm | 624 nm | 25.90% | 670 nm laser | 0.10 W cm−2 | QY = 0.64 (1O2) |
| 100% was eliminated by N-GQDs (5.1%) after a 3-min exposure | [ |
| CDs | citric acid and ethylenediamine | 350 nm * | 450 nm | 20% | LED light (365 nm) | 3 V/3 W. | QY = 0.82 (1O2) |
| bacteria growth inhibition efficiencies of 92% and 86% were obtained for | [ |
| BrCDs | natural gas, HBr | 302 nm | >355 nm | -- | Ultraviolet lamp (365 nm) | 3 mW | -- |
| with 10 min of UV exposure the growth of each bacterium is further decreased, achieving minimal to no colony formation visible for each | [ |
| EDA-CDs/EPA-CDs | carbon nano-powders | -- | -- | 20% | 400–800 nm light bulb | 36 W, 12 V | -- |
| 1 h of EDA-CDs and EPA-CDs treatment resulted in a reduction of approximately 5.80 log and 0.84 log, respectively | [ |
| FCDs | glucosamine hydrochloride and m-phenylenediamine | -- | -- | -- | blue-LED strip lights (460 nm) | 24 W, 12 V | -- |
| complete killing of each bacterium was reproducibly observed after treatment with 200 µg/mL FCDs with 4 h of irradiation, and significant killing (>95%) could be observed after only 90 min LED irradiation | [ |
|
| ||||||||||
| CDs-AMP | citric acid and ethylenediamine | 350 nm | 450 nm | 19% | visible light | 0.30 W | -- |
| >4 log10 inhibition of | [ |
| BSA-CDs NP | 1,5-dihydroxyanthraquinone | 395 nm | 525 nm | 75% (CDs) | Tungsten bulb (300–900 nm) | 100 W | -- |
| 99.97% and 99.53% elimination of | [ |
|
| ||||||||||
| CDs/MB or CDs/TB | carbon nanopowders | 400 nm | -- | 12% (CDs) | white light bulb | 36 W | -- |
| 5 μg/mL CDs combined with 1 μg/mL MB completely inhibited bacteria growth, resulting in 6.20 log viable cell number reduction | [ |
| GQDs | sulfur and nickel (II) oxide powder and benzene | 310 nm | 420 nm | -- | 660 nm red light | 12 W | -- |
| 106 CFU/mL | [ |
| cur-GQDs | coal and curcumin | 407 nm | 525–550 nm * | -- | 405 nm LEDs | 30 J cm−2. | -- | for | [ | |
| CDs/Cur | citric acid and thiourea | 420 nm | 550–575 nm* | -- | 405 + 808 nm light | 808 nm (500 mW cm−2), 405 nm (200 mW cm−2) | -- |
| death rate of | [ |
| CD-DNA-PpIX hybrid hydrogel | citric acid and Branched Polyethylenimine | 350 nm | 625–650 nm * | -- | UV lamp (302 nm) | -- | -- |
| UV irradiation for 2.50 min followed by incubation for 24 h affected > 4.50 log (>99.99%) reduction of | [ |
|
| ||||||||||
| ZnO/GQDs | citric acid | 365 nm | 460 nm | -- | UV light (365nm) | 100 W, 1000–1500 lumen | -- |
| 100% was eliminated by ZnO/GQDs after 5 min of UV exposure | [ |
|
| ||||||||||
| CDgel | ammonium citrate and polyethylenimine | 390 nm | 400–500 nm | -- | white light irradiation | 5 mW cm−2 | -- |
| CDgel under light giving approximately 99% and 97% mortality for | [ |
| BC/ | Citric, urea and CuCl2·2H2O | 360 nm | 722 nm | -- | 808 nm | 2 W cm−2 | -- |
| antibacterial rate up to 99.60% and 99.99% to | [ |
a Labels indicate either additional details regarding the nature of the reported carbon dots or indicate the abbreviation/common label used within the cited study to describe the particle. * Denotes values extrapolated from relevant in-text details from the specified reference.